Thyroid cancer: ALKBH5 inhibits the progression of thyroid cancer by enhancing ferroptosis through Nrf2 inactivation mediated by decreasing the m6A level in TIAM1.223 FTO inhibits the progression of thyroid cancer by inducing ferroptosis through m6A-mediated downregulation of SLC7A11.224. Here, SLC7A11 is linked to thyroid cancer.